{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:40:20Z","timestamp":1792611620779,"version":"4.5.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.contraception.2012.05.018","type":"journal-article","created":{"date-parts":[[2012,7,7]],"date-time":"2012-07-07T00:50:18Z","timestamp":1341622218000},"page":"666-672","source":"Crossref","is-referenced-by-count":23,"title":["User characteristics and out-of-pocket expenditures for progestin-only versus combined oral contraceptives"],"prefix":"10.1016","volume":"86","author":[{"given":"Su-Ying","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Grossman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn A.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2012.05.018_bb0005","first-page":"1","article-title":"Use of contraception in the United States: 1982\u20132008","volume":"23","author":"Mosher","year":"2010","journal-title":"Vital Health Stat"},{"key":"10.1016\/j.contraception.2012.05.018_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.contraception.2012.01.008","article-title":"Contraindications to progestin-only oral contraceptive pills among reproductive-aged women","author":"White","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.05.018_bb0015","unstructured":"MD Consult drug monographs. Available at: http:\/\/www.mdconsult.com. Accessed May 26, 2009."},{"key":"10.1016\/j.contraception.2012.05.018_bb0020","first-page":"1","article-title":"Centers for Disease Control and Prevention. U.S. medical eligibility criteria for contraceptive use","volume":"59","year":"2010","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.contraception.2012.05.018_bb0025","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/humrep\/14.4.982","article-title":"A comparison of the inhibition of ovulation achieved by desogestrel 75 micrograms and levonorgestrel 30 micrograms daily","volume":"14","author":"Rice","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2012.05.018_bb0030","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/GCO.0b013e3282f1e7b6","article-title":"Recent advances in hormonal contraception","volume":"19","author":"Erkkola","year":"2007","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.05.018_bb0035","first-page":"36","article-title":"Out-of-pocket expenditures for oral contraceptives and number of packs per purchase","volume":"59","author":"Phillips","year":"2004","journal-title":"J Am Med Womens Assoc"},{"key":"10.1016\/j.contraception.2012.05.018_bb0040","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.contraception.2010.09.013","article-title":"Women's out-of-pocket expenditures and dispensing patterns for oral contraceptive pills between 1996 and 2006","volume":"83","author":"Liang","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.05.018_bb0045","first-page":"373","article-title":"The Medical Expenditure Panel Survey: a national health information resource","volume":"33","author":"Cohen","year":"1996","journal-title":"Inquiry"},{"key":"10.1016\/j.contraception.2012.05.018_bb0050","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/AOG.0b013e31820b0244","article-title":"Contraindications to combined oral contraceptives among over-the-counter compared with prescription users","volume":"117","author":"Grossman","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.05.018_bb0055","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.contraception.2005.04.009","article-title":"Cervical cancer screening continues to limit provision of contraception","volume":"72","author":"Schwarz","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.05.018_bb0060","unstructured":"Agency for Healthcare Research and Quality. Using appropriate price indices for analyses of health care expenditures or income across multiple years. Available at http:\/\/www.meps.ahrq.gov\/mepsweb\/about_meps\/Price_Index.shtml. Accessed January 13, 2010."},{"key":"10.1016\/j.contraception.2012.05.018_bb0065","doi-asserted-by":"crossref","unstructured":"Freeman S, Shulman LP. Considerations for the use of progestin-only contraceptives. J Am Acad Nurse Pract;22:81\u201391.","DOI":"10.1111\/j.1745-7599.2009.00473.x"},{"key":"10.1016\/j.contraception.2012.05.018_bb0070","unstructured":"Grimes DA, Lopez LM, O'Brien PA, Raymond EG. Progestin-only pills for contraception. Cochrane Database Syst Rev:CD007541."},{"key":"10.1016\/j.contraception.2012.05.018_bb0075","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1097\/01.AOG.0000239122.98508.39","article-title":"Number of oral contraceptive pill packages dispensed, method continuation, and costs","volume":"108","author":"Foster","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.05.018_bb0080","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/AOG.0b013e3182056309","article-title":"Number of oral contraceptive pill packages dispensed and subsequent unintended pregnancies","volume":"117","author":"Foster","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2012.05.018_bb0085","series-title":"Initial national priorities for comparative effectiveness research","article-title":"Committee on Comparative Effectiveness Research Prioritization, Institute of Medicine","year":"2009"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782412002673?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782412002673?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T03:50:55Z","timestamp":1542858655000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782412002673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0010782412002673"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2012.05.018","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}